PRODUCT : DIASET-M1/M2

CATEGORY :
ANTI-DIABETIC
Composition :
Glimepiride 1, 2 mg + Metformin 500 mg SR Tablets
Indication
Type 2 diabetes (NIDDM).
Dosage
O.D. can be titrated to B.D.
Contraindications
Hypersensitivity diabetic ketoacidosis; renal dysfunction; acute or chronic metabolic acidosis.
Precautions
Renal & hepatic impairment. Hypoglycaemic episodes.
Mechanism Of Action
Dual Action of Glimepiride & Metformin. Glimepiride is a medium-to-long acting sulfonylurea drug act on 65 kda sulfonyl urea receptor present in pancreatic beta cells. Glimepiride lowers the blood glucose level by stimulating pancreatic beta cells to produce more insulin and by inducing increased activity of intracellular insulin receptors and metformin improves hyperglycemia primarily through its suppression of hepatic glucose production and increases insulin sensitivity thus enhances peripheral glucose uptake and delay the absorption of glucose from the gastrointestinal tract.
DISCLAIMER : This product is available only in India against valid prescription from a Registered Medical Practitioner. This is not an offer for sale.